Edit

Prolacta Bioscience

http://www.prolacta.com/

Last activity: 19.02.2026

Active

Categories: BioTechHealthcareInfantHealthNutritionPharmaceuticals

Founded in 1999, Prolacta Bioscience is the leading provider of 100% human milk-based neonatal nutritional products to hospital neonatal intensive care units (NICUs).

Likes

6.25K

Followers

1.81K

Followers

4.54K

Website visits

22.3K /mo.

Mentions

Location: United States

Employees: 201-500

Phone: +1 626-599-9260

Total raised: $56M

Founded date: 1999

Investors 7

Date	Name	Website
-	Alta Partn...	altapartne...
-	Frontier V...	draperfron...
-	Aisling Ca...	aislingcap...
-	Mercury Fu...	mercuryfun...
-	Frontier O...	frontiervc...
-	EW Healthc...	ewhealthca...
-	PROOF Fund	proof.vc

Funding Rounds 3

Date	Series	Amount	Investors
15.05.2018	-	$9M	-
06.12.2016	-	$35M	-
23.05.2007	-	$12M	-

Mentions in press and media 22

Date	Title	Description
19.02.2026	A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants	Japan's Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort® Enteral Solution as Prescription Medicine in the NICU DUARTE, Calif., Feb. 19, 2026 /PRNewswire/ -- Prolacta Bioscience® today announced that Japan's Ministry of He...
12.02.2026	Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan	Clinigen obtained approval for Prolacta's "PreemieFort® Enteral Solution", a human milk-based fortifier, as an approved pharmaceutical product in Japan indicated for the "Nutritional management of neonates and infants present...
13.05.2025	Improved Survival and Growth While Cutting Malnutrition for Premature Infants Fed Human Milk-Based Fortifiers at Sydney Hospital	Study Demonstrates Multiple Benefits of Prolacta's Exclusive Human Milk Diet Compared to Traditional Cow Milk-Based Feeding Protocol ADELAIDE, Australia, May 13, 2025 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provid...
10.12.2024	Adoption of an Exclusive Human Milk Diet Reduces Malnutrition Rates Among Vulnerable Premature Infants in Sydney Hospital	Preliminary Data From Observational Study Presented at Australian and New Zealand Neonatal Network Clinical Practice Improvement Conference ADELAIDE, Australia, Dec. 10, 2024 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospita...
21.10.2024	The Battle for Baby Nutrition: A New Dawn for Premature Infants in Australia	In the world of neonatal care, every ounce counts. For premature infants, the right nutrition can mean the difference between life and death. Recent developments in Australia highlight a significant shift in how these vulnerable babies are ...
21.10.2024	Humavant® 100% Human Milk-Based Fortifiers Helping Premature Infants in Australia Grow and Develop	Human Milk-Based Nutrition Is Clinically Demonstrated to Improve Health Outcomes in Very Low Birth Weight Babies Compared to Cow Milk-Based Products ADELAIDE, Australia, Oct. 21, 2024 /PRNewswire/ -- Prolacta Bioscience®, the world's leadin...
04.10.2021	EW Healthcare Partners Announces the Promotion of Senior Executives	Oct 04 2021 NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the promotion of senior executives of their investment team. • Brooks Andrews has bee...
10.11.2020	Prolacta Bioscience Fortifiers Reduce Risk of Serious Lung Disease and Hospital Costs Among Premature Infants, Compared to Cow Milk-Based Fortifiers
04.11.2020	Pushing for US & Middle East to eat organic, Saudi prince joins Back To The Roots round	KBW Ventures, the early-stage investment firm run by Saudi Arabian prince Khaled bin Alwaleed bin Talal Al Saud, has joined an investment round into Oakland, California’s organic gardening company Back to the Roots. The round, of undisclose...
02.07.2020	MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings	Jul 02 2020 Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management. EW Healthcare Partners Managing Director and Co-Founder Martin Sutter and Former Medtronic Chairman and CEO William Hawkin...
20.01.2020	Why is a vegan Saudi prince investing in breast milk made from stem cells?	TurtleTree Labs, a Singapore-based biotech startup that has invited AFN to taste a glass of its lab-grown mother’s milk this spring, has completed its pre-seed funding round. Alternative protein investors Lever VC led the round. They were j...
22.08.2019	EW Healthcare Partners Raises Over $745 Million Fund 2	Aug 22 2019 Team of Experienced Healthcare Investors and Former Healthcare Executives Will Invest in Select Healthcare Companies to Seek to Accelerate Their Revenue Growth Partner and Principals Promoted in London, New York and Palo Alto ...
15.05.2018	Prolacta Bioscience Raises $9 Million	-
24.04.2017	The appetite for breast milk has produced a growing commodity market	She was donating the milk because she didn’t need it anymore. Her son, a young toddler, had recently graduated to solid food, but her freezer at home was still packed with pumped milk. “I didn’t know what to do with it,” a harried-looking S...
06.12.2016	Prolacta Bioscience Raises $35 Million in Mezzanine Financing	Dec 06 2016 CITY OF INDUSTRY, California – Prolacta Bioscience®, the nation’s leading provider of human milk-based neonatal nutritional products, today announced the closing of a $35 million mezzanine round of financing. The transaction wa...
06.12.2016	Prolacta Bioscience® Raises $35 Million in Mezzanine Financing	CITY OF INDUSTRY, CA–(Marketwired – Dec 6, 2016) – Prolacta Bioscience®, the nation’s leading provider of human milk-based neonatal nutritional products, today announced the closing of a $35 million mezzanine round of financing. The transac...
03.11.2011	Prolacta Bioscience Raises Series D funding from Health Evolution Partners	Prolacta Bioscience, a Monrovia, Calif.-based life science company that offers human milk fortifier (HMF) made from 100% human breast milk for critically ill, premature infants, has raised an undisclosed sum of Series D funding from Health ...
03.11.2011	Prolacta Lands Series D	Monrovia, California-based Prolatca Bioscience, which supplies human milk-based fortifiers for premature infants, said today that it has closed a Series D funding round. The round came from Health Evolution Partners. Size of the round was n...
26.07.2007	Funding roundup: Announcements that got away	Although I try to stay on top of events in the life sciences, announcements do sometimes manage to slip through the cracks. Some days, in fact, I end up triaging. Because the roots of this site — not to mention many of its readers — are in ...
23.05.2007	Prolacta Bioscience Raises $12M	Monrovia-based Prolacta Bioscience has raised $12M in a funding round, the firm said today, in a round led by Alta Partners. The round also included DFJ Frontier, Arcturus Capital, DFJ Mercury, Funk Ventures, Phillip Capital, Gideon Hixon F...
04.10.2006	Prolacta Raises $5M	Monrovia-based Prolacta Bioscience has raised $5M, in a Series B prime financing round. The firm said that the funding came from Arcturus Capital, DFJ Mercury, Philip Capital, Funk Ventures Capital, and the Gideon Hixon Fund, along with exi...
-	The appetite for breast milk has produced a growing commodity market	Rebecca Soltes walked into a gaily decorated hospital meeting room, pushing her kids in a double stroller and carrying a soft-sided cooler filled with bags of frozen breast milk — 100 ounces of the stuff. She dropped it on a table, and the ...

Prolacta Bioscience

Investors 7

Funding Rounds 3

Mentions in press and media 22

Reviews 0